Camurus AB is a research-based pharmaceutical company focused on developing innovative, long-acting medicines to improve the lives of people with severe and chronic conditions including cancer, opioid dependence, and endocrine disease. Based in Sweden, the company operates internationally, bringing treatments to patients worldwide.
Operating within the pharmaceutical and biotechnology sectors, Camurus AB specialises in developing specialty medicines based on its proprietary FluidCrystal® technology to create long-acting treatments. The aim is to develop and market innovative, differentiated medicines for significant medical needs.
Monitor the CAMX.ST share price by adding it to your eToro watchlist
This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.